Applied Clinical Trials-03-01-2018

Applied Clinical Trials

Europe Adds More Voices to Orphan Drug Push

March 01, 2018

News

27

3

Rare disease interests in Europe add more voices to push for greater backing of research incentives, infrastructure.

Removing the Risks from Adaptive Pathways: Planning for the Possible?

March 01, 2018

News

27

3

Peter O’Donnell weighs the varying views in Europe on the risks of going the adaptive pathways route for drug approval.

The Promise of Liquid Biopsy Technology

March 01, 2018

Feature Article

27

3

The ability to diagnose cancer at earlier stages of the disease is constrained by the specificity and mechanics of traditional diagnostic methods. The growing use of liquid biopsy technology may help overcome such barriers and potentially revolutionize cancer research, patient treatment, and survivor care.

Surmounting eClinical Data Volume and Diversity

March 01, 2018

Clinical Trial Insights

27

3

Amid industry feedback that the growing volume and diversity of eClinical data collected for studies is taxing cycle times, two studies highlight the need to optimize protocol design and executional complexity to overcome these data management burdens.

Specialized Safety Needs for Small and Midsize Companies

March 01, 2018

Feature Article

27

3

Meeting today’s complex regulatory demands when it comes to drug safety and pharmacovigilance can be especially challenging for small and medium-sized organizations. This report presents the benefits for these companies in outsourcing such activities to functional service providers (FSPs) during clinical trials and post-approval.

Applied Clinical Trials, March 2018 Issue (PDF)

March 01, 2018

Issue PDF

27

3

Click the title above to open the Applied Clinical Trials March 2018 issue in an interactive PDF format.